10706
H. Horibe et al. / Tetrahedron 60 (2004) 10701–10709
NMR (CDCl3): dZ0.89 (s, 9H), 1.70–1.82 (m, 3H), 2.04–
2.20 (br, 1H), 2.71–2.89 (br, 1H), 2.96–3.05 (m, 1H), 3.11
(dd, JZ9.1, 4.1 Hz, 1H), 3.23–3.35 (br, 1H), 4.16–4.31 (br,
1H), 7.16 (dd, JZ12.7, 8.6 Hz, 1H), 7.37–7.60 (m, 9H),
7.65–7.81 (m, 4H), 7.84 (d, JZ7.8 Hz, 1H), 8.23 (br d, JZ
7.8 Hz, 1H). 13C NMR (CDCl3): 24.60, 27.35, 29.45, 54.02,
64.32, 64.50, 71.93, 124.78, 124.98, 125.41, 126.02, 127.38,
127.87, 128.06, 128.49, 129.31, 129.50, 130.79, 130.83,
130.88, 130.92, 131.21, 131.35, 131.63, 131.77, 133.72,
133.92, 135.25, 135.48, 136.72, 136.75, 152.08, 152.14.
FABMS: m/zZ484 (MCC1).
2.88–3.04 (br, 1H), 3.12–3.23 (m, 2H), 4.22 (s, 2H), 6.89–
7.02 (m, 2H), 7.06–7.13 (m, 2H), 7.15–7.49 (m, 9H), 7.61–
7.76 (m, 5H). FABMS: m/zZ482 (MCC1).
4.2.6.
(S)-N-[2-(Diphenylphosphanyl)-6-methoxyl-
phenyl]-2-(pyrrolidinylmethyl)pyrrolidine (1l). The
representative 2-step procedure was used to afford the title
ligand 1l (yield 31%) as a colorless viscous oil. The physical
data were comparable to those reported.18a
4.2.7.
(S)-N-[2-(Diphenylphosphanyl)-6-methoxyl-
4.2.4. (S)-N-[2-(Di-p-tolylphosphanyl)naphthalen-1-yl]-
2-(benzyloxymethyl)pyrrolidine (1f). The representative
2-step procedure was used to afford the title ligand 1f (yield
48%) as a colorless viscous oil. [a]2D4ZC818 (c 0.47, THF).
phenyl]-2-methylpiperidine (1m). The representative
2-step procedure was used to afford the title ligand 1m
(yield 30%) as a colorless amorphous. [a]2D5ZK238 (c 3.51,
dioxane). IR (neat): nZ1283, 1258 cmK1 1H NMR
.
1
IR (neat): nZ1374, 1308, 1113 cmK1. H NMR (CDCl3,
(CDCl3): dZ0.67 (d, JZ6.3 Hz, 3H), 1.03–1.35 (m, 4H),
1.48 (brd, JZ8.3 Hz, 1H), 1.60–1.68 (br, 1H), 2.46 (brd,
JZ11.1 Hz, 1H), 2.94 (ddd, JZ11.1, 11.1, 3.3 Hz 1H),
3.20–3.32 (m, 1H), 3.77 (s, 3H), 6.36 (brd, JZ8.1 Hz 1H),
6.81 (d, JZ8.1 Hz, 1H), 7.02 (dd, JZ8.1, 8.1 Hz, 1H),
7.22–7.36 (m, 10H). 13C NMR (CDCl3): 20.03, 20.08,
25.40, 25.84, 35.20, 52.41, 54.98, 55.18, 111.90, 124.71,
126.09, 126.11, 127.77, 127.82, 127.87, 127.92, 133.87,
134.12, 134.18, 134.42, 138.04, 138.22, 138.91, 139.12,
141.67, 141.79, 141.82, 141.97, 158.83, 158.86. FABMS:
m/zZ390 (MCC1). Anal. Calcd for C25H28NOP: C, 77.10;
H, 7.25; N, 3.60. Found: C, 76.96; H, 7.33; N, 3.41. The
physical data of the coupling product in the first step, (S)-N-
[2-(diphenylphosphinoyl)-6-methoxylphenyl]-2-methyl-
piperidine, with small amounts of inseparable impurities are
shown below. This mixture was used for the second step, the
reduction reaction, without further separation. IR (nujol):
nZ1283, 1267, 1190 cmK1. 1H NMR (CDCl3): dZ0.52 (d,
JZ6.4 Hz, 3H), 0.83–1.00 (m, 1H), 1.08–1.34 (m, 4H),
1.79–1.91 (br, 1H), 2.87–2.95 (m, 2H), 3.16–3.30 (m, 1H),
3.80 (s, 3H), 6.62 (ddd, JZ13.5, 7.3, 1.6 Hz, 1H), 6.99–7.10
(m, 2H), 7.36–7.50 (m, 6H), 7.73–7.83 (m, 4H). 13C NMR
(CDCl3): 19.75, 24.88, 25.42, 34.06, 54.29, 55.19, 55.85,
115.59, 115.62, 125.50, 125.73, 125.88, 126.06, 127.62,
127.73, 127.80, 127.90, 130.48, 130.50, 130.52, 130.54,
131.19, 131.32, 131.56, 131.69, 133.53, 134.00, 135.07,
135.55, 144.08, 144.15, 159.84, 159.99. FABMS: m/zZ406
(MCC1).
50 8C): dZ1.90–2.09 (br, 3H), 2.22–2.45 (m, 7H), 3.20–
3.41 (m, 4H), 4.10–4.30 (br, 3H), 6.98–8.25 (m, 19H). 13C
NMR (CDCl3): 21.32, 25.24, 30.26, 54.63, 63.22, 63.32,
72.88, 74.61, 125.58, 126.04, 126.15, 127.02, 127.22,
127.90, 127.98, 129.01, 129.11, 133.44, 133.58, 133.74,
133.88, 137.84, 137.95, 138.81. FABMS: m/zZ530 (MCC
1). Anal. Calcd for C36H36NOP: C, 81.64; H, 6.85; N, 2.64.
Found: C, 81.35; H, 6.70; N, 2.65. The physical data of the
coupling product in the first step, (S)-N-[2-(di-p-tolyl-
phosphinoyl)naphthalen-1-yl]-2-(benzyloxymethyl)pyrroli-
dine, with small amounts of inseparable impurities are
shown below. This mixture was used for the second step, the
reduction reaction, without further separation. IR (neat): nZ
1383, 1310, 1186, 1113 cmK1. 1H NMR (CDCl3): dZ1.56–
1.73 (br, 1H), 1.78–1.94 (m, 2H), 2.12–2.29 (br, 1H), 2.36
(s, 6H), 2.80–2.99 (br, 1H), 3.11–3.27 (m, 2H), 3.28–3.46
(br, 1H), 4.11 (s, 2H), 4.27–4.48 (br, 1H), 7.03 (br d, JZ
6.8 Hz, 2H), 7.11–7.32 (m, 8H), 7.36–7.67 (m, 7H), 7.83 (d,
JZ8.1 Hz, 1H), 8.14–8.24 (br, 1H). 13C NMR (CDCl3):
21.58, 24.81, 29.57, 54.21, 63.38, 72.56, 73.88, 124.80,
124.99, 125.47, 125.73, 126.88, 126.95, 127.43, 127.87,
128.69, 128.75, 128.83, 128.88, 128.93, 129.50, 129.69,
130.34, 130.81, 131.34, 131.48, 131.67, 131.81, 132.40,
136.72, 138.71, 141.19, 141.23, 141.27, 151.86. FABMS:
m/zZ546 (MCC1).
4.2.5. (S)-N-[2-(Diphenylphosphanyl)-6-methylphenyl]-
2-(benzyloxymethyl)pyrrolidine (1k). The representative
2-step procedure was used to afford the title ligand 1l (yield
50%) as a colorless viscous oil. [a]2D4ZC508 (c 0.647,
1
4.2.8. (E)-1-Bromo-2-(4-triisopropylsilyloxymethyl-
phenyl)ethene (3e). To a stirred solution of (E)-1-bromo-
2-(4-hydroxymethylphenyl)ethene (134 mg, 0.632 mmol)
and imidazole (94.2 mg, 1.37 mmol) in DMF (0.6 mL)
was gradually added TIPSCl (240 mg, 1.24 mmol) at 0 8C.
The reaction mixture was stirred for 1.5 h at rt and purified
directly by silica gel column (hexane) to gave 1-bromo-2-
(4-triisopropylsilyloxymethylphenyl)ethene (3e) (230 mg,
99%) as a colorless oil. IR (neat): nZ1462, 1094 cmK1. 1H
NMR (CDCl3): dZ0.97–1.24 (m, 3H), 1.09 (d, JZ5.6 Hz,
18H), 4.81 (s, 2H), 6.74 (d, JZ14.0 Hz, 1H), 7.09 (d,
JZ14.0 Hz, 1H), 7.26 (d, JZ8.3 Hz, 2H), 7.31 (d, JZ
8.3 Hz, 2H). 13C NMR (CDCl3): dZ12.00, 18.01, 64.63,
105.68, 125.73, 125.87, 134.23, 136.82, 141.71. EIMS:
THF). IR (neat): nZ1095 cmK1. H NMR (CDCl3): dZ
1.49–1.90 (m, 3.5H), 1.99–2.20 (m, 1.2H), 2.27 (s, 3H),
2.60–2.80 (m, 0.6H), 2.85 (dd, JZ7.6, 7.6 Hz, 0.9H), 3.09–
3.36 (m, 2H), 3.64–3.80 (m, 0.8H), 4.27 (s, 2H), 6.61–6.84
(br, 0.8H), 7.01 (dd, JZ7.4, 7.4 Hz, 1H), 6.97–7.40 (16.2H).
FABMS: m/zZ466 (MCC1). EIMS: m/zZ344 (MCK
CH2OBn, bp), 91. HRMS (MCKCH2OBn): calcd for
C23H23NP: 344.1568; found: 344.1549. The physical data
of the coupling product in the first step, (S)-N-[2-
(diphenylphosphinoyl)-6-methylphenyl]-2-(benzyloxy-
methyl)pyrrolidine, with small amounts of inseparable
impurities are shown below. This mixture was used for
the second step, the reduction reaction, without further
separation. IR (neat): nZ1454, 1418, 1200, 1113 cmK1. 1H
NMR (CDCl3, 50 8C): dZ1.30–1.51 (br, 1H), 1.54–1.72 (m,
2H), 1.90–2.05 (m, 2H), 2.29 (s, 3H), 2.43–2.68 (br, 1H),
m/zZ370 (MC), 368 (MC), 325 (bp), 195. HRMS: m/z
79
calcd for C18H BrOSi: 368.1171; found: 368.1180.
29